CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 88,812	$ 126,184
Research and development incentive receivable	629	1,998
Prepaid expenses and other current assets	4,472	1,096
Total current assets	93,913	129,278
Property and equipment, net	1,334	403
Goodwill	27,109	27,109
Right-of-use assets	8,222	1,959
Other assets	2,548	1,949
Total assets	133,126	160,698
Current liabilities:
Accounts payable	3,891	2,088
Accrued expenses	8,532	6,461
Current portion of lease liability	756	898
Total current liabilities	13,179	9,447
Long-term debt, including accretion, net of discount	25,537	20,097
Lease liabilities	4,677	1,918
Other liabilities	25	16
Total liabilities	43,418	31,478
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common stock, $0.001 par value, 125,000,000 and 33,333,333 shares authorized as of September 30, 2020 and December 31, 2019, respectively; 16,286,645 and 16,128,862 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively	16	16
Additional paid-in capital	265,586	261,367
Accumulated other comprehensive loss	(119)	(119)
Accumulated deficit	(175,775)	(132,044)
Total stockholders’ equity	89,708	129,220
Total liabilities and stockholders’ equity	$ 133,126	$ 160,698